NM_000843.4:c.1308T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000843.4(GRM6):c.1308T>C(p.Thr436Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.997 in 1,614,002 control chromosomes in the GnomAD database, including 802,671 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 73899 hom., cov: 33)
Exomes 𝑓: 1.0 ( 728772 hom. )
Consequence
GRM6
NM_000843.4 synonymous
NM_000843.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.68
Publications
14 publications found
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
ZNF454 (HGNC:21200): (zinc finger protein 454) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 5-178988981-A-G is Benign according to our data. Variant chr5-178988981-A-G is described in ClinVar as Benign. ClinVar VariationId is 198105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.985 AC: 149841AN: 152130Hom.: 73843 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
149841
AN:
152130
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.996 AC: 248874AN: 249816 AF XY: 0.997 show subpopulations
GnomAD2 exomes
AF:
AC:
248874
AN:
249816
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.999 AC: 1459591AN: 1461754Hom.: 728772 Cov.: 54 AF XY: 0.999 AC XY: 726213AN XY: 727162 show subpopulations
GnomAD4 exome
AF:
AC:
1459591
AN:
1461754
Hom.:
Cov.:
54
AF XY:
AC XY:
726213
AN XY:
727162
show subpopulations
African (AFR)
AF:
AC:
31660
AN:
33476
American (AMR)
AF:
AC:
44624
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
26131
AN:
26132
East Asian (EAS)
AF:
AC:
39698
AN:
39700
South Asian (SAS)
AF:
AC:
86212
AN:
86232
European-Finnish (FIN)
AF:
AC:
53398
AN:
53398
Middle Eastern (MID)
AF:
AC:
5714
AN:
5726
European-Non Finnish (NFE)
AF:
AC:
1111945
AN:
1111988
Other (OTH)
AF:
AC:
60209
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
125
250
376
501
626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21670
43340
65010
86680
108350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.985 AC: 149957AN: 152248Hom.: 73899 Cov.: 33 AF XY: 0.986 AC XY: 73420AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
149957
AN:
152248
Hom.:
Cov.:
33
AF XY:
AC XY:
73420
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
39362
AN:
41556
American (AMR)
AF:
AC:
15242
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
3472
AN:
3472
East Asian (EAS)
AF:
AC:
5132
AN:
5132
South Asian (SAS)
AF:
AC:
4830
AN:
4830
European-Finnish (FIN)
AF:
AC:
10622
AN:
10622
Middle Eastern (MID)
AF:
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
AC:
68005
AN:
68012
Other (OTH)
AF:
AC:
2087
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
120
241
361
482
602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3467
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Nov 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital stationary night blindness 1B Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.